Filter
News & Insights
- Wealth & Investment Management
Conference speaking and how (not) to do it!
Read More - FinTech
Finovate Podcast Episodes: 201-210
Read More - FinTech
“Digitize or Die”: A Call to Arms for Building Societies
Read More - Clinical & Medical AffairsClinical Insider
Alcanza buys FDI in tenth takeover since 2021
Read More - Clinical & Medical AffairsClinical Insider
Quanticate teams with machine learning firm PhaseV with an eye on adaptive trials
Read More - Clinical & Medical AffairsClinical Insider
Patient group says online tool will help connect myeloma sufferers with studies
Read More - Private Capital
Decoding private capital: A conversation with Ashley Roche, MEMCO
Read More - Clinical & Medical AffairsClinical Insider
Ulysses secures funding for hiring and expansion odyssey
Read More - Clinical & Medical AffairsClinical Insider
A2 Healthcare sets up in Boston to help biopharma with Japanese trials
Read More - Clinical & Medical AffairsClinical Insider
Influenza highest pandemic risk according to EU clinical research network
Read More - Wealth & Investment Management
3 lessons in climate litigation around the world
Read More - Wealth & Investment Management
Adjusted For Risk Podcast: An investment management special
Read More - Clinical & Medical AffairsClinical Insider
CDER launches C3TI to drive innovation in clinical trials
Read More - Clinical & Medical AffairsClinical Insider
NCTN to use Natera biomarker to guide treatment in urothelial cancer trial
Read More - Clinical & Medical AffairsClinical Insider
Explainer animations increasingly common in UK clinical trials, says study
Read More - Clinical & Medical AffairsClinical Insider
Experts predict tech innovation will establish three-phase trial model for new drugs
Read More - Partnering, Business Development & Licensing
Moving from Eminence-Based to Evidence-Based Healthcare
Read More - Clinical & Medical AffairsClinical Insider
EMA shares details of stakeholder collaboration platform
Read More - Clinical & Medical AffairsClinical Insider
Resonance Health to buy TrialsWest to build presence in study space
Read More - Clinical & Medical AffairsClinical Insider
Study says regulations covering multi-drug “platform studies” should be more flexible
Read More